• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number UNK-CV-SR-VALIANT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Dyspnea (1816); Pain (1994); Heart Failure/Congestive Heart Failure (4446); Swelling/ Edema (4577); Insufficient Information (4580)
Event Date 09/15/2021
Event Type  Death  
Event Description
Valiant navion stent grafts were implanted during the endovascular treatment of a 60mm descending thoracic aortic aneurysm (taa) on an unknown date in 2007.A non mdt stent graft was implanted to treat a 50mm infrarenal aaa.It was reported approximately 2 years post the index procedure follow up echo demonstrated the patient had developed symptomatic of left ventricular hypertrophy with diastolic dysfunction.The patient had bilateral lower limb oedema, with on and off chest pain and shortness of breath.On further follow up the patient had developed q-t interval with resultant new-onset atrial fibrillation.It was reported 9 years post the index procedure the patient expired due to fatal cardiac arrhythmia.
 
Manufacturer Narrative
Medtronic received the following information obtained from the journal article entitled; combined thoracic endovascular aortic repair and endovascular aneurysm repair and the long-term consequences of altered cardiovascular haemodynamics on morbidity and mortality: case series and literature review sultan et al, european heart journal - case reports (2021) 5(10), 1¿10 case reports (2021) 5(10), 1¿10 doi:10.1093/ehjcr/ytab339.Other relevant device(s) are:s/n: unknown; use by date: unknown; upn # unknown.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
B5; correction to ed; valiant stent grafts were implanted during the endovascular treatment of a 60mm descending thoracic aortic aneurysm (taa) on an unknown date.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key13024017
MDR Text Key282378311
Report Number9612164-2021-04908
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeEI
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-CV-SR-VALIANT
Device Catalogue NumberUNK-CV-SR-VALIANT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/15/2021
Initial Date FDA Received12/17/2021
Supplement Dates Manufacturer Received01/11/2022
Supplement Dates FDA Received02/03/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
"SEE H10...."
Patient Outcome(s) Death;
Patient Age61 YR
Patient SexMale
-
-